Skip to main content

Spectrum: Autism Research News

Author

Laura Dattaro

Former Senior News Writer

Laura Dattaro was a senior reporter at Spectrum from 2020 to 2023, where she covered genetics, mental health, public policy and other areas of autism research. She proposed and wrote the Null and Noteworthy newsletter, a monthly recap of studies with null results and replications. Dattaro has worked as a science journalist and editor for more than 10 years and has written for the Columbia Journalism ReviewPopular MechanicsSlate and The New York Times, among other publications. Before joining Spectrum, she also worked as associate producer for the World Science Festival. Dattaro has an M.A. in science and health journalism from Columbia University and a B.A. in English and music from the University of Delaware. You can find her on Twitter at @LauraLauraDat.

July 2021
Week of JulyJul
12th
2021

Spotted around the web: Microbiota therapies, face processing in autism, Ninja Training

Here is a roundup of news and research for the week of 12 July.

Comments
Immature inhibitory cells surround mature neuron.

Critical time window flagged for autism gene’s influence

by  /  16 July 2021

A transplant of inhibitory neurons during the second week of life prevents social difficulties and a brain signaling imbalance in mice missing a copy of FOXG1.

Comments
Illustration of hybrid objects: part light bulb, part lab vial, some in blue and some in red to signify null and replicated results

Null and Noteworthy: Oxytocin, parental training, outcome assessments

by  /  15 July 2021

In this edition of Null and Noteworthy, researchers open the case on acetaminophen and close it on oxytocin.

Comments
large, diverse group of people.

Federal autism committee names new members

by  /  7 July 2021

The U.S. government today announced the latest iteration of the Interagency Autism Coordinating Committee, the body of scientists and advocates that helps set priorities for federally funded autism research and services.

Comments
June 2021
Close up of phone with Cognoa app in use, apparently taking video or a photo of a child exhibiting stimming behaviors or repetitive motions.

Green light for diagnostic autism app raises questions, concerns

by  /  24 June 2021

The U.S. Food and Drug Administration has given the okay to an app designed to help clinicians diagnose autism in children, but some researchers have concerns about its use.

Comments
Scientist with diagnostic tool, looking at many different choices, including the number 6.

How two graduate students uncovered a critical error in autism screening guidelines

by  /  22 June 2021

Spectrum spoke to the researchers who uncovered an error in autism screening guidelines that have been in use for nearly a decade.

Comments
Two people having an intense conversation, one unable to make direct eye contact.

Alexithymia, not autism, may drive eye-gaze patterns

by  /  14 June 2021

How autistic people look at a face may be linked more to alexithymia, a condition marked by difficulties recognizing one’s own emotions, than to autism.

Comments
May 2021

Autism research funding rises but still falls short of goals

by  /  31 May 2021

Federal funding for autism research increased by $23.2 million from 2016 to 2018, according to the latest report from the Interagency Autism Coordinating Committee.

Comments
Illustration of hybrid objects: part light bulb, part lab vial, some in blue and some in red to signify null and replicated results

Null and Noteworthy: Pregnancy factors, household language, toddler tests

by  /  20 May 2021

In this edition of Null and Noteworthy, researchers rebut a controversial epidural study, test out autism assessments in toddlers and give the okay for multilingualism in autistic children.

Comments
Portrait of Dr. Georgia Panagiotakos on a hill in San Francisco, with a view of the city behind her and her pet dog.

Beyond the bench: A conversation with Georgia Panagiotakos

by  /  11 May 2021

Georgia Panagiotakos reflects on how to keep lab work fun during tough times.

Comments